These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 36604359)

  • 1. Acute, chronic, and post-mortem toxicity: a review focused on three different classes of new psychoactive substances.
    Rodrigues CHP; Mariotto LS; Castro JS; Peruquetti PH; Silva-Junior NC; Bruni AT
    Forensic Toxicol; 2023 Jul; 41(2):187-212. PubMed ID: 36604359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic Cannabinoids and Cathinones Cardiotoxicity: Facts and Perspectives.
    Radaelli D; Manfredi A; Zanon M; Fattorini P; Scopetti M; Neri M; Frisoni P; D'Errico S
    Curr Neuropharmacol; 2021; 19(11):2038-2048. PubMed ID: 33845747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature.
    Chiappini S; Mosca A; Miuli A; Santovito MC; Orsolini L; Corkery JM; Guirguis A; Pettorruso M; Martinotti G; Di Giannantonio M; Schifano F
    Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34204131
    [No Abstract]   [Full Text] [Related]  

  • 4. The Growing Problem of New Psychoactive Substances (NPS).
    Madras BK
    Curr Top Behav Neurosci; 2017; 32():1-18. PubMed ID: 27571747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of the effects of novel psychoactive substances 'legal highs' on people with severe mental illness.
    Gray R; Bressington D; Hughes E; Ivanecka A
    J Psychiatr Ment Health Nurs; 2016 Jun; 23(5):267-81. PubMed ID: 27037639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of New Psychoactive Substances (NPS) in northeast Brazil: NMR-based identification and analysis of ecstasy tablets by GC-MS.
    Cunha RL; Oliveira CDSL; de Oliveira AL; Maldaner AO; do Desterro Cunha S; Pereira PAP
    Forensic Sci Int; 2023 Mar; 344():111597. PubMed ID: 36801502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recreational use, analysis and toxicity of tryptamines.
    Tittarelli R; Mannocchi G; Pantano F; Romolo FS
    Curr Neuropharmacol; 2015 Jan; 13(1):26-46. PubMed ID: 26074742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Toxicology of New Psychoactive Substances: Synthetic Cathinones and Phenylethylamines.
    Tyrkkö E; Andersson M; Kronstrand R
    Ther Drug Monit; 2016 Apr; 38(2):190-216. PubMed ID: 26587869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of synthetic substances in France and in Europe].
    Debruyne D; Monzon E; Perino J; Haramburu F; Daveluy A; Lazès-Charmetant A; Giraudon I
    Therapie; 2021; 76(3):221-228. PubMed ID: 32859404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profile, effects, and toxicity of novel psychoactive substances: A systematic review of quantitative studies.
    Assi S; Gulyamova N; Ibrahim K; Kneller P; Osselton D
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28631432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New psychoactive substances (NPS) prevalence over LSD in blotter seized in State of Santa Catarina, Brazil: A six-year retrospective study.
    de Souza Boff B; Silveira Filho J; Nonemacher K; Driessen Schroeder S; Dutra Arbo M; Rezin KZ
    Forensic Sci Int; 2020 Jan; 306():110002. PubMed ID: 31864775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New psychoactive substances of natural origin: A brief review.
    Feng LY; Battulga A; Han E; Chung H; Li JH
    J Food Drug Anal; 2017 Jul; 25(3):461-471. PubMed ID: 28911631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New psychoactive substances in Taiwan: The current situation and initiative for rational scheduling.
    Yu WJ; Cottler L; Li JH
    J Food Drug Anal; 2021 Mar; 29(1):168-181. PubMed ID: 35696229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of cathinones and other new psychoactive substances in hair of parents and children of families with known or suspected parental abuse of conventional illegal drugs.
    Niebel A; Pragst F; Krumbiegel F; Hartwig S
    Forensic Sci Int; 2022 Feb; 331():111148. PubMed ID: 34923263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scheduling of new psychoactive substance the Swiss way: A review and critical analysis.
    Grafinger KE; Bernhard W; Weinmann W
    Sci Justice; 2019 Jul; 59(4):459-466. PubMed ID: 31256819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic drugs of abuse.
    Tamama K
    Adv Clin Chem; 2021; 103():191-214. PubMed ID: 34229850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New and Emerging Illicit Psychoactive Substances.
    Graddy R; Buresh ME; Rastegar DA
    Med Clin North Am; 2018 Jul; 102(4):697-714. PubMed ID: 29933824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Psychoactive Substances: The Razor's Edge between Therapeutical Potential and Psychoactive Recreational Misuse.
    Correia B; Fernandes J; Botica MJ; Ferreira C; Quintas A
    Medicines (Basel); 2022 Mar; 9(3):. PubMed ID: 35323718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring psychoactive substance use at six European festivals through wastewater and pooled urine analysis.
    Bijlsma L; Celma A; Castiglioni S; Salgueiro-González N; Bou-Iserte L; Baz-Lomba JA; Reid MJ; Dias MJ; Lopes A; Matias J; Pastor-Alcañiz L; Radonić J; Turk Sekulic M; Shine T; van Nuijs ALN; Hernandez F; Zuccato E
    Sci Total Environ; 2020 Jul; 725():138376. PubMed ID: 32298891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel psychoactive substances-related presentations to the emergency departments of the European drug emergencies network plus (Euro-DEN plus) over the six-year period 2014-2019.
    Crulli B; Dines AM; Blanco G; Giraudon I; Eyer F; Liechti ME; Miró Ò; Hovda KE; Heyerdahl F; Yates C; Vallersnes OM; Wood DM; Dargan PI;
    Clin Toxicol (Phila); 2022 Dec; 60(12):1318-1327. PubMed ID: 36322684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.